Lugano, Switzerland

Nadia Puppini

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Como, IT (2008 - 2012)
  • Lugano, CH (2020)

Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nadia Puppini: Innovator in Hormonal Solutions

Introduction

Nadia Puppini is a notable inventor based in Lugano, Switzerland. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral solutions for steroid hormones. With a total of four patents to her name, her work focuses on enhancing the bioavailability of these hormones.

Latest Patents

Nadia's latest patents include innovative aqueous oral solutions of steroid hormones, specifically Progesterone and Testosterone, complexed with hydroxypropyl-beta-cyclodextrin. These formulations are designed for oral administration and are characterized by a specific molar ratio that ensures high hormone plasma levels. The optimization of solubility, permeability, metabolic stability, and bioavailability allows for effective plasma concentrations following oral administration of lower doses. This advancement offers greater safety and compliance for patients compared to existing oral formulations on the market.

Career Highlights

Throughout her career, Nadia has worked with reputable companies such as Altergon SA and IBSA Institut Biochemique S.A. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations and formulations.

Collaborations

Nadia has collaborated with professionals like Giorgio Zoppetti and Marco Pizzutti, further enhancing her research and development efforts in the field of hormonal solutions.

Conclusion

Nadia Puppini stands out as an influential inventor in the realm of pharmaceutical innovations, particularly in the development of oral steroid hormone solutions. Her work continues to impact patient safety and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…